SYNB

Putnam BioRevolution ETF [SYNB] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

SYNB Stock Summary

Top 10 Correlated ETFs

SYNB

Top 10 Correlated Stocks

SYNB

In the News

SYNB Financial details

Company Rating
-
Market Cap
5.43M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.02
Dividend %
0.07%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-1.55%
SMA50
-3.58%
SMA100
-8.99%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
24.466-31.1
52W High
-4.19%
52W Low
+23.75%
RSI
41.47
Rel Volume
0.23
Avg Volume
432
Volume
100
Perf Week
-0.3%
Perf Month
-1.26%
Perf Quarter
-9.81%
Perf Half Y
-9.12%
-
-
-
-
Beta
0.908273
-
-
Volatility
0.12%, 0.4%
Prev Close
-1.13%
Price
29.7
Change
-1.13%

SYNB Financial Performance

SYNB Dividend History

SYNB Frequently Asked Questions

What is Putnam BioRevolution ETF stock symbol ?

Putnam BioRevolution ETF is a US stock and trading under the symbol SYNB

What is Putnam BioRevolution ETF stock quote today ?

Putnam BioRevolution ETF stock price is $29.7 today.

Is Putnam BioRevolution ETF stock public?

Yes, Putnam BioRevolution ETF is a publicly traded company.

Something similar

Top by Market Cap
3V64.DE
GOOG
BRK-A
MSFT
MIX.JO
Top Correlated ETFs
MOTE
XHE
MDEV
PSCD
MOAT
Top Correlated Stocks
DIN
AB
OWL
ANSS
NSIT
Similar Market Cap
AVCO
RUEH.TO
DBGI
BLOE.L
DBOX.L

Company Profile

Financial Services Asset Management
  • Volume Average 432
  • Market Capitalization 5.43M
  • Headquarters US
  • IPO Date 2022-09-30

The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.